P3 Health Partners Inc. (NASDAQ:PIII) Q1 2024 Earnings Call Transcript

Jack Senft: Okay, perfect. That makes sense. Thanks. And if I can just sneak one final one. In terms of the ACO REACH contribution, can you just talk about your longer-term vision for the program? And how — I guess, or if ACO REACH will eventually contribute to your results. Just kind of curious if you can just double click on what your long-term vision is here? Thanks.

Bill Bettermann: Yes. Thanks so much. This is Bill. So, as you’ve heard in prior calls with us, the ACO REACH program is something that we’re getting in, not just a toehold that we’re going all in this past year. And we’ve grown substantially from 2023 to 2024 in all of our markets. With that being said, as Dr. Coffman alluded to in the beginning, we’re very — going to be approaching this very carefully using our data analytics to look at where we’re having success, where we have opportunities to continue to grow in this particular platform. But we’re excited about where we’re at. We’ve had some nice successes last year and into this year. Dr. Bacchus, anything you want to add?

Amir Bacchus: The only thing I would add is, Jack, as you’ve heard us talk about before, with our providers that we have about 2,700 or so providers and the MA lives that we have with them, the ACO REACH gives us a much bigger, deeper opportunity to go into each of those practices for more mind share with those clinicians. So, as those clinicians instead of having 100, 200 with us, now we got 300, 400 or so with us, it just creates an overall better mousetrap to drive better performance for their understanding of value-based care overall.

Operator: This will conclude today’s conference call. Thank you for attending.